Skip to content

Helmerich & Payne HP Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Patterson-UTI Energy logo
Patterson-UTI EnergyPTEN
SM Energy logo
SM EnergySM
Noble Corporation logo
Noble CorporationNE
Valaris logo
ValarisVAL
Halliburton logo
HalliburtonHAL
Oceaneering International logo
Oceaneering InternationalOII

Other financials

Income statement

See full
Revenue$932.4M-8.2%
Gross profit$271.2M-13.7%
Operating income-$36.9M-188%
Net income-$58.6M-3,643%
EPS (diluted)-$0.59-6,000%

Balance sheet

See full
Cash & equivalents$204.0M-16.7%
Total debt$2.0B-10.6%
Total equity$2.6B-13.8%
Total assets$6.3B-12.5%

Cash flow

See full
Operating cash flow$36.6M-34.7%
CapEx$62.9M-60.4%
Free cash flow$114.9M+121%

Valuation

See full
Market cap$3.56B+41.1%

Profitability

See full
Gross margin31.5%-5.8pp
Operating margin3.3%-13.2pp
Net margin-9.4%-16.5pp
FCF margin4.4%-3.0pp

Returns & leverage

See full
Return on equity-13.2%-20.7pp
Debt / equity0.8×0.0×
Current ratio1.7×0.0×

Where this comes from

Reported directly by Helmerich & Payne in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Helmerich & Payne’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Helmerich & Payne's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Helmerich & Payne's common stock, shares authorized (in shares)?
Helmerich & Payne (HP) reported common stock, shares authorized (in shares) of $160M in Q1 2026.
How has Helmerich & Payne's common stock, shares authorized (in shares) changed year-over-year?
Helmerich & Payne's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $160M to $160M.
What is the long-term trend for Helmerich & Payne's common stock, shares authorized (in shares)?
Over 5 years (2020 to 2025), Helmerich & Payne's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $160M to $160M.